Irhythm Technologies Inc (IRTC) Stock Price, Quote & News

Company Profile

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) moni...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 632 5700

Website: www.irhythmtech.com

Address:

699 8th Street, Suite 600, San Francisco, United States

11thestate Jun. 8 at 2:43 PM

Settlement Update: iRhythm Technologies ($IRTC) The proposed $45M iRhythm settlement has advanced to the Stipulation of Settlement stage, meaning the parties have formally agreed to resolve the case and are now seeking court approval. The case covers investors who purchased $IRTC shares between July 25, 2022 and August 29, 2024. We have every detail, including how investors can get paid: https://11th.com/cases/irhythm-investor-settlement

0 · Reply

MarketBeat May. 18 at 11:03 AM

https://marketbeat.com/a/8661047/ $IRTC iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains

0 · Reply

BillionerOfKing May. 5 at 9:42 PM

$IRTC Current Stock Price: $118.11 Contracts to trade: $120.0 IRTC May 15 2026 Call Entry: $2.35 Exit: $3.21 ROI: 37% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday May. 1 at 3:42 PM

$IRTC Share Price: $120.50 Contract Selected: Nov 20, 2026 $140 Calls Buy Zone: $8.84 – $10.92 Target Zone: $14.47 – $17.69 Potential Upside: 55% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

StocktwitsEarnings Apr. 30 at 8:18 PM

$IRTC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.43 up 55.67% YoY • Reported revenue of $199.39M up 25.66% YoY • iRhythm increased its fiscal year 2026 revenue guidance to a range of $875M to $885M and adjusted EBITDA margin guidance to 12.0% to 13.0%, reflecting continued volume-led growth and operating leverage.

0 · Reply

Estimize Apr. 30 at 3:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +3.67M Revs compared to WS http://www.estimize.com/irtc/fq1-2026?utm_conten

0 · Reply

NorthStarStats Apr. 28 at 12:57 AM

More low scores from the momentum scanner, but some exciting news. These are setups to watch and study, not trade recommendations. $CRMD Score 90 (BREAKOUT WATCH!), $ADM Score 93, $VST Score 73, $MGM Score 70, $IRTC Score 70

0 · Reply

BioTechHealthX Apr. 26 at 6:18 PM

$IRTC iRhythm Technologies (NASDAQ: IRTC) is revolutionizing heart monitoring with AI-powered diagnostics. With strong clinical data and rising adoption, this stock could be a major player in the future of digital healthcare. https://biotechhealthx.com/biotech-news/is-it-a-great-move-to-invest-in-irhythm-technologies-irtc/

0 · Reply

TipRanks Apr. 24 at 10:09 AM

2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On https://www.tipranks.com/news/article/2-under-the-radar-wearable-ai-stocks-analysts-are-bullish-on $AMBQ $IRTC

0 · Reply

BioTechHealthX Apr. 23 at 12:06 AM

$BSX $IRTC $TEM $TDOC $VEEV Looking for the best AI healthcare stocks? These top 5 best medical AI companies are leading the next wave of innovation in diagnostics, telemedicine, and drug development—before Wall Street fully catches on. https://biotechhealthx.com/biotech-news/top-5-best-medical-ai-stocks-that-could-deliver-100-returns/

0 · Reply

iRhythm Holdings Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 9:00 AM EDT - 12 days ago

iRhythm Holdings Slides: 46th Annual William Blair Growth Stock Conference

2026-06-01T12:01:15.000Z - 13 days ago

iRhythm price target lowered to $152 from $180 at Canaccord

May 27, 2026, 12:00 PM EDT - 18 days ago

iRhythm Holdings Transcript: AGM 2026

May 19, 2026, 4:05 PM EDT - 26 days ago

iRhythm Holdings to Participate in Upcoming Investor Conferences

2026-05-18T12:08:16.000Z - 27 days ago

iRhythm price target lowered to $180 from $225 at BofA

May 13, 2026, 12:20 PM EDT - 4 weeks ago

iRhythm Holdings Transcript: Bank of America Global Healthcare Conference 2026

2026-05-04T10:51:11.000Z - 5 weeks ago

iRhythm price target raised to $157 from $155 at Citi

2026-05-01T15:13:53.000Z - 6 weeks ago

iRhythm price target raised to $174 from $170 at Truist

2026-05-01T14:39:20.000Z - 6 weeks ago

iRhythm price target raised to $175 from $166 at Baird

2026-05-01T12:56:35.000Z - 6 weeks ago

iRhythm price target lowered to $175 from $215 at JPMorgan

2026-05-01T12:32:50.000Z - 6 weeks ago

iRhythm price target lowered to $185 from $225 at Oppenheimer

2026-05-01T12:17:43.000Z - 6 weeks ago

iRhythm price target lowered to $160 from $170 at Evercore ISI

2026-05-01T11:41:39.000Z - 6 weeks ago

iRhythm price target raised to $255 from $254 at Needham

2026-05-01T10:48:25.000Z - 6 weeks ago

iRhythm price target lowered to $180 from $198 at Canaccord

Apr 30, 2026, 4:30 PM EDT - 6 weeks ago

iRhythm Holdings Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 6 weeks ago

iRhythm Holdings Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 6 weeks ago

iRhythm Holdings Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 6 weeks ago

iRhythm Holdings Quarterly report: Q1 2026

2026-04-30T20:15:43.000Z - 6 weeks ago

iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M

Apr 30, 2026, 4:05 PM EDT - 6 weeks ago

iRhythm Holdings Announces First Quarter 2026 Financial Results

Apr 28, 2026, 4:05 PM EDT - 6 weeks ago

iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference

Apr 27, 2026, 8:05 AM EDT - 6 weeks ago

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

Apr 17, 2026, 8:00 AM EDT - 2 months ago

iRhythm Holdings Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

iRhythm Holdings Proxy statement: Proxy filing

Apr 16, 2026, 4:05 PM EDT - 2 months ago

iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026

2026-04-15T12:43:35.000Z - 2 months ago

iRhythm price target lowered to $170 from $200 at Truist

2026-04-13T12:02:30.000Z - 2 months ago

iRhythm price target lowered to $185 from $215 at BTIG

Apr 9, 2026, 6:44 PM EDT - 2 months ago

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

2026-04-07T10:59:33.000Z - 2 months ago

iRhythm price target lowered to $155 from $214 at Citi

2026-04-06T12:17:21.000Z - 2 months ago

iRhythm price target lowered to $170 from $210 at Evercore ISI

Apr 6, 2026, 8:00 AM EDT - 2 months ago

iRhythm Holdings Proxy statement: Proxy filing

Mar 30, 2026, 8:05 AM EDT - 2 months ago

Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

Mar 12, 2026, 4:30 PM EDT - 3 months ago

iRhythm Holdings Appoints Jason Patten to its Board of Directors

2026-03-11T09:25:40.000Z - 3 months ago

iRhythm price target lowered to $214 from $242 at Citi

Feb 19, 2026, 4:30 PM EST - 4 months ago

iRhythm Holdings Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:30 PM EST - 4 months ago

iRhythm Holdings Annual report: Q4 2025

Feb 19, 2026, 4:30 PM EST - 4 months ago

iRhythm Holdings Earnings release: Q4 2025

Feb 19, 2026, 4:30 PM EST - 4 months ago

iRhythm Holdings Slides: Q4 2025

Feb 19, 2026, 4:05 PM EST - 4 months ago

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

Feb 5, 2026, 4:30 PM EST - 4 months ago

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Jan 29, 2026, 5:02 PM EST - 4 months ago

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 15, 2026, 11:22 AM EST - 5 months ago

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 12, 2026, 11:15 AM EST - 5 months ago

iRhythm Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 5 months ago

iRhythm Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 AM EST - 5 months ago

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:30 PM EST - 5 months ago

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 4, 2025, 9:10 AM EST - 6 months ago

iRhythm Holdings Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 1:00 PM EST - 6 months ago

iRhythm Holdings Transcript: Citi Annual Global Healthcare Conference 2025

Nov 20, 2025, 5:00 AM EST - 7 months ago

iRhythm Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:20 AM EST - 7 months ago

iRhythm Holdings Transcript: Wolfe Research Healthcare Conference 2025

Nov 11, 2025, 8:05 AM EST - 7 months ago

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Nov 5, 2025, 1:38 PM EST - 7 months ago

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

Nov 4, 2025, 4:30 PM EST - 7 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

Oct 30, 2025, 4:30 PM EDT - 8 months ago

iRhythm Holdings Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 8 months ago

iRhythm Holdings Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 8 months ago

iRhythm Holdings Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 8 months ago

iRhythm Holdings Slides: Q3 2025

Oct 30, 2025, 4:05 PM EDT - 8 months ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Oct 16, 2025, 4:30 PM EDT - 8 months ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

Sep 18, 2025, 1:30 PM EDT - 9 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

Sep 10, 2025, 12:50 PM EDT - 9 months ago

iRhythm Holdings Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 2:35 PM EDT - 9 months ago

iRhythm Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 12:45 PM EDT - 10 months ago

iRhythm Holdings Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 29, 2025, 7:00 AM EDT - 10 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 18, 2025, 8:05 AM EDT - 10 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Jul 31, 2025, 4:30 PM EDT - 11 months ago

iRhythm Holdings Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

iRhythm Holdings Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

iRhythm Holdings Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

iRhythm Holdings Slides: Q2 2025

Jul 31, 2025, 4:05 PM EDT - 11 months ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 25, 2025, 6:35 PM EDT - 11 months ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 17, 2025, 4:30 PM EDT - 11 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 11, 2025, 10:12 PM EDT - 1 year ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 7, 2025, 8:30 AM EDT - 1 year ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jun 23, 2025, 8:30 AM EDT - 1 year ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 17, 2025, 1:40 PM EDT - 1 year ago

iRhythm Holdings Transcript: 2025 Truist Securities MedTech Conference

Jun 10, 2025, 2:40 PM EDT - 1 year ago

iRhythm Holdings Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 4, 2025, 3:00 PM EDT - 1 year ago

iRhythm Holdings Transcript: 45th Annual William Blair Growth Stock Conference

Jun 4, 2025, 3:00 PM EDT - 1 year ago

iRhythm Holdings Slides: 45th Annual William Blair Growth Stock Conference

May 13, 2025, 6:40 PM EDT - 1 year ago

iRhythm Holdings Transcript: Bank of America 2025 Healthcare Conference

May 1, 2025, 4:30 PM EDT - 1 year ago

iRhythm Holdings Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

iRhythm Holdings Quarterly report: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

iRhythm Holdings Earnings release: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

iRhythm Holdings Slides: Q1 2025

May 1, 2025, 4:10 PM EDT - 1 year ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 1 year ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 1 year ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 1 year ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 1 year ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Apr 16, 2025, 8:00 AM EDT - 1 year ago

iRhythm Holdings Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

iRhythm Holdings Proxy statement: Proxy Filing

Mar 31, 2025, 8:05 AM EDT - 1 year ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Feb 20, 2025, 4:30 PM EST - 1 year ago

iRhythm Holdings Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

iRhythm Holdings Annual report: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

iRhythm Holdings Earnings release: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

iRhythm Holdings Slides: Q4 2024

Feb 20, 2025, 4:05 PM EST - 1 year ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

11thestate Jun. 8 at 2:43 PM

0 · Reply

MarketBeat May. 18 at 11:03 AM

https://marketbeat.com/a/8661047/ $IRTC iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains

0 · Reply

BillionerOfKing May. 5 at 9:42 PM

0 · Reply

SuperGreenToday May. 1 at 3:42 PM

0 · Reply

StocktwitsEarnings Apr. 30 at 8:18 PM

0 · Reply

Estimize Apr. 30 at 3:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +3.67M Revs compared to WS http://www.estimize.com/irtc/fq1-2026?utm_conten

0 · Reply

NorthStarStats Apr. 28 at 12:57 AM

0 · Reply

BioTechHealthX Apr. 26 at 6:18 PM

0 · Reply

TipRanks Apr. 24 at 10:09 AM

2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On https://www.tipranks.com/news/article/2-under-the-radar-wearable-ai-stocks-analysts-are-bullish-on $AMBQ $IRTC

0 · Reply

BioTechHealthX Apr. 23 at 12:06 AM

0 · Reply

jb02345 Mar. 11 at 3:52 PM

$IRTC always goes up after earnings. Accumulate now

0 · Reply

JR679 Feb. 23 at 6:12 PM

$IRTC

0 · Reply

JR679 Feb. 20 at 1:59 PM

$IRTC

0 · Reply

StocktwitsEarnings Feb. 19 at 9:22 PM

$IRTC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.17 up 525.00% YoY • Reported revenue of $208.89M up 27.12% YoY • For the full year 2026, iRhythm expects revenue of $870M to $880M and adjusted EBITDA margin of 11.5% to 12.5%, reflecting continued volume-led growth and gross margin expansion.

0 · Reply

Estimize Feb. 19 at 4:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +2.40M Revs compared to WS http://www.estimize.com/irtc/fq4-2025?utm_conten

0 · Reply

SuperGreenToday Feb. 12 at 10:14 AM

$IRTC Share Price: $152.14 Contract Selected: Aug 21, 2026 $150 Calls Buy Zone: $18.02 – $22.25 Target Zone: $34.15 – $41.74 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Feb. 2 at 4:13 PM

$IRTC Share Price: $157.71 Contract Selected: Aug 21, 2026 $170 Calls Buy Zone: $14.96 – $18.48 Target Zone: $25.71 – $31.43 Potential Upside: 62% ROI Time to Expiration: 199 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Jan. 30 at 3:44 PM

$IRTC Share Price: $151.19 Contract Selected: Aug 21, 2026 $145 Calls Buy Zone: $19.80 – $24.47 Target Zone: $34.70 – $42.41 Potential Upside: 65% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Leondog1992 Jan. 30 at 3:23 PM

$APGE $IRTC $MDB $HL $IESC

0 · Reply

Leondog1992 Jan. 29 at 7:04 PM

$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king

1 · Reply

Market Cap	5.78B
Revenue (ttm)	591.84M
Net Income (ttm)	-113.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.14%
Debt to Equity Ratio	0.00

Volume	1,454,100
Avg Vol	495,702
Day's Range	N/A - N/A
Shares Out	32.22M
Stochastic %K	35%
Beta	1.12
Analysts	Strong Sell
Price Target	$219.64